agilon health (AGL) Competitors $3.78 -0.15 (-3.70%) As of 04/24/2025 03:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AGL vs. HIMS, GH, OPCH, RDNT, PIII, SHC, BTSG, PRVA, WGS, and SGRYShould you be buying agilon health stock or one of its competitors? The main competitors of agilon health include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), P3 Health Partners (PIII), Sotera Health (SHC), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), GeneDx (WGS), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. agilon health vs. Hims & Hers Health Guardant Health Option Care Health RadNet P3 Health Partners Sotera Health BrightSpring Health Services Privia Health Group GeneDx Surgery Partners agilon health (NYSE:AGL) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, risk, community ranking, profitability, institutional ownership, analyst recommendations, earnings and valuation. Does the media prefer AGL or HIMS? In the previous week, Hims & Hers Health had 19 more articles in the media than agilon health. MarketBeat recorded 30 mentions for Hims & Hers Health and 11 mentions for agilon health. Hims & Hers Health's average media sentiment score of 0.87 beat agilon health's score of 0.73 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment agilon health 6 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 18 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in AGL or HIMS? 63.5% of Hims & Hers Health shares are held by institutional investors. 3.2% of agilon health shares are held by company insiders. Comparatively, 17.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher earnings and valuation, AGL or HIMS? Hims & Hers Health has lower revenue, but higher earnings than agilon health. agilon health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratioagilon health$6.06B0.26-$262.60M-$0.63-6.06Hims & Hers Health$1.48B4.23-$23.55M$0.5452.11 Which has more volatility & risk, AGL or HIMS? agilon health has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 1.65, indicating that its stock price is 65% more volatile than the S&P 500. Does the MarketBeat Community prefer AGL or HIMS? agilon health received 11 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 43.90% of users gave agilon health an outperform vote while only 36.44% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformagilon healthOutperform Votes5443.90% Underperform Votes6956.10% Hims & Hers HealthOutperform Votes4336.44% Underperform Votes7563.56% Do analysts rate AGL or HIMS? agilon health presently has a consensus target price of $4.60, indicating a potential upside of 20.32%. Hims & Hers Health has a consensus target price of $38.25, indicating a potential upside of 35.93%. Given Hims & Hers Health's stronger consensus rating and higher possible upside, analysts plainly believe Hims & Hers Health is more favorable than agilon health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score agilon health 2 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.06Hims & Hers Health 2 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.21 Is AGL or HIMS more profitable? Hims & Hers Health has a net margin of 8.19% compared to agilon health's net margin of -6.88%. Hims & Hers Health's return on equity of 10.97% beat agilon health's return on equity.Company Net Margins Return on Equity Return on Assets agilon health-6.88% -47.84% -14.97% Hims & Hers Health 8.19%10.97%8.29% SummaryHims & Hers Health beats agilon health on 15 of the 18 factors compared between the two stocks. Get agilon health News Delivered to You Automatically Sign up to receive the latest news and ratings for AGL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AGL vs. The Competition Export to ExcelMetricagilon healthhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$1.57B$1.93B$5.41B$18.86BDividend YieldN/A7.15%5.44%4.15%P/E Ratio-4.0615.4622.1832.40Price / Sales0.263.90397.3128.58Price / CashN/A9.3238.2017.53Price / Book2.343.986.834.44Net Income-$262.60M$87.49M$3.20B$1.02B7 Day Performance-5.07%8.14%5.77%3.35%1 Month Performance-14.54%-7.73%-4.32%-5.48%1 Year Performance-25.54%-27.84%17.88%4.28% agilon health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AGLagilon health1.8269 of 5 stars$3.82-2.6%$4.60+20.3%-28.3%$1.57B$6.06B-4.06650Gap UpHIMSHims & Hers Health3.8482 of 5 stars$28.21+3.6%$38.25+35.6%+128.1%$6.27B$1.48B64.12650Insider TradeGHGuardant Health3.821 of 5 stars$45.16+3.3%$49.00+8.5%+161.9%$5.57B$739.02M-12.691,790Upcoming EarningsAnalyst RevisionNews CoverageOPCHOption Care Health3.1674 of 5 stars$31.84+0.9%$33.00+3.6%+7.5%$5.23B$5.00B26.765,600Upcoming EarningsAnalyst ForecastPositive NewsHigh Trading VolumeRDNTRadNet3.9103 of 5 stars$53.36-0.1%$69.75+30.7%+3.7%$3.95B$1.83B-762.188,970Positive NewsPIIIP3 Health Partners1.7283 of 5 stars$8.99+18.6%$0.25-97.2%-62.0%$3.23B$1.50B-10.70500High Trading VolumeSHCSotera Health2.6238 of 5 stars$10.62+1.0%$15.20+43.1%+0.3%$3.01B$1.10B42.483,000Upcoming EarningsAnalyst ForecastBTSGBrightSpring Health Services2.7824 of 5 stars$17.10+0.1%$21.67+26.7%+53.5%$2.99B$11.27B-65.7735,000Upcoming EarningsNews CoveragePositive NewsPRVAPrivia Health Group3.9206 of 5 stars$24.05-0.2%$26.87+11.7%+29.1%$2.92B$1.74B240.52810Positive NewsWGSGeneDx2.13 of 5 stars$101.04+4.6%$72.33-28.4%+825.5%$2.84B$305.45M-51.551,200Upcoming EarningsPositive NewsSGRYSurgery Partners2.6923 of 5 stars$21.32+1.6%$36.63+71.8%-14.4%$2.72B$3.11B-44.4213,500Positive News Related Companies and Tools Related Companies Hims & Hers Health Alternatives Guardant Health Alternatives Option Care Health Alternatives RadNet Alternatives P3 Health Partners Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives Privia Health Group Alternatives GeneDx Alternatives Surgery Partners Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:AGL) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding agilon health, inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share agilon health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.